1. Siege, J.P. Rituximab approval letter. FDA 97-0244.
2. Therapeutic antibodies: market considerations, disease targets and bioprocessing;Elvin;Int J Pharmaceut,2013
3. Babiuch, A.S. New monoclonal antibody treatments in retina. Retin Physician 14, 22–25.
4. Drug discovery in ophthalmology: past success, present challenges, and future opportunities;Gower;BMC Ophthalmol,2016
5. Anti-VEGF treatment strategies for Wet AMD;Kovach;J Ophthalmol,2012